Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00642213 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites

Study acronym: GCNKSS
StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 24, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
  2. Primary and study completion dates: Apr 1, 2025 to Jun 30, 2025v10
  3. Re-verified, no change to tracked fieldsv9
  4. Primary and study completion dates: Apr 2020 to Apr 1, 2025 Study description expanded, about 3 wordsv8 Show 1 more changeShow less
    • Study description expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  5. Enrollment target: 1200 to 1500 Secondary endpoints: details revised at 1 of 1 entryv7 Show 1 more changeShow less
    • Secondary endpoints: details revised at 1 of 1 entry
Show 5 earlier versionsHide 5 earlier versions
  1. Secondary endpoints: details revised at 1 of 1 entryv6
  2. Re-verified, no change to tracked fieldsv5
  3. Enrollment target: 516 to 1200 Primary and study completion dates: Jan 2015 to Apr 2020 · Study description expanded, about 172 wordsv4 Show 2 more changesShow less
    • Primary and study completion dates: Jan 2015 to Apr 2020
    • Study description expanded, about 172 words

    See this version in full on ClinicalTrials.gov ↗

  4. Primary and study completion dates: Jun 2014 to Jan 2015v3
  5. Primary and study completion dates: Jun 2009 to Jun 2014 Enrollment target: 502 to 516 · Start date: Jul 2004 to Jul 1993 · Eligibility criteria revisedv2 Show 3 more changesShow less
    • Enrollment target: 502 to 516
    • Start date: Jul 2004 to Jul 1993
    • Eligibility criteria revised

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Cincinnati
68 trials monitored
See 6 trials at risk
Stroke
3,289 trials monitored
See 141 trials at risk
Our primary goal is to study temporal trends in the incidence rate, causes, treatment, and outcome of stroke among a large biracial metropolitan population of 1,349,351, of whom 215,611 (15%) are black (2000 Census). Such data are critical for the planning, intervention, and evaluation of public health efforts to decrease the mortality and morbidity due to stroke in the United States. We have completed this goal for 1993-94, 1999, 2005, 2010 and 2015. We are in the process of collecting this data for 2020. In the 2020 study period we will also be ascertaining 3 year recurrence rates for all incident stroke events.
Trial Details
NCT Number NCT00642213
Lead Sponsor University of Cincinnati
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Ischemic Stroke, TIA, Hemorrhage
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov